tbuckley/cabot-search huggingface dataset:
A multi-trait embodied framework for the evolution of brains and cognition across animal phyla
Authors: Sheryl Coombs, Michael Trestman
Journal: Behavioral and Brain Sciences (2024)

Among non-human animals, crows, octopuses and honeybees are well-known for their complex brains and cognitive abilities. Widening the lens from the idiosyncratic abilities of exemplars like these to those of animals across the phylogenetic spectrum begins to reveal the ancient evolutionary process by which complex brains and cognition first arose in different lineages. The distribution of 35 phenotypic traits in 17 metazoan lineages reveals that brain and cognitive complexity in only three lineages (vertebrates, cephalopod mollusks, and euarthropods) can be attributed to the pivotal role played by body, sensory, brain and motor traits in active visual sensing and visuomotor skills. Together, these pivotal traits enabled animals to transition from largely reactive to more proactive behaviors, and from slow and two-dimensional motion to more rapid and complex three-dimensional motion. Among pivotal traits, high-resolution eyes and laminated visual regions of the brain stand out because they increased the processing demands on and the computational power of the brain by several orders of magnitude. The independent acquisition of pivotal traits in cognitively complex (CC) lineages can be explained as the completion of several multi-trait transitions over the course of evolutionary history, each resulting in an increasing level of complexity that arises from a distinct combination of traits. Whereas combined pivotal traits represent the highest level of complexity in CC lineages, combined traits at lower levels characterize many non-CC lineages, suggesting that certain body, sensory and brain traits may have been linked (the trait-linkage hypothesis) during the evolution of both CC and non-CC lineages.
A digital, decentralized trial of exercise therapy in patients with cancer
Authors: Whitney P. Underwood, Meghan G. Michalski, Catherine P. Lee, Gina A. Fickera, Su S. Chun, Stefan E. Eng, Lydia Y. Liu, Brandon L. Tsai, Chaya S. Moskowitz, Jessica A. Lavery, Kimberly J. Van Zee, Ginger J. Gardner, Jennifer J. Mueller, Chau T. Dang, Behfar Ehdaie, Vincent P. Laudone, James A. Eastham, Jessica M. Scott, Paul C. Boutros, Lee W. Jones
Journal: npj Digital Medicine (2024)

We developed and evaluated the Digital Platform for Exercise (DPEx): a decentralized, patient-centric approach designed to enhance all aspects of clinical investigation of exercise therapy. DPEx integrated provision of a treadmill with telemedicine and remote biospecimen collection permitting all study procedures to be conducted in patient's homes. Linked health biodevices enabled high-resolution monitoring of lifestyle and physiological response. Here we describe the rationale and development of DPEx as well as feasibility evaluation in three different cohorts of patients with cancer: a phase 0a development study among three women with post-treatment primary breast cancer; a phase 0b proof-of-concept trial of neoadjuvant exercise therapy in 13 patients with untreated solid tumors; and a phase 1a level-finding trial of neoadjuvant exercise therapy in 53 men with localized prostate cancer. Collectively, our study demonstrates the utility of a fully digital, decentralized approach to conduct clinical trials of exercise therapy in a clinical population.
Twenty-year trends in excess costs of chronic obstructive pulmonary disease
Authors: Joseph Emil Amegadzie, Jeenat Mehareen, Amir Khakban, Phalgun Joshi, Chris Carlsten, Mohsen Sadatsafavi
Journal: European Respiratory Journal (2024)

Background Several major risk factors for chronic obstructive pulmonary disease (COPD), such as population aging, smoking rates, and air pollution levels are rapidly changing, causing inevitable changes in the population burden of COPD. We determined the excess direct costs of COPD and their trend from 2001 to 2020. Methods Using administrative health data from British Columbia, Canada, we created a retrospective matched cohort of physician-diagnosed COPD patients and non-COPD individuals. Excess direct medical costs (2020 $CAD) were estimated by analysing hospital records, outpatient services, medications, and community-care services. Comorbidity classes were assessed using the International Classification of Diseases codes. Excess COPD costs were estimated as the adjusted difference in direct medical costs between COPD and non-COPD cohorts. Results There were 208 554 and 404 703 individuals in the COPD and non-COPD cohorts, respectively (47.8% female; mean baseline age 69.1 and 68.2 years, respectively). Direct medical costs for COPD were $9224 per patient-year (/PY), compared to $3396/PY for non-COPD, giving rise to excess costs of $5828/PY (95% confidence interval [CI] 5759–5897). Excess costs increased by 48% over the study period. Excess costs due to comorbidities were $3588/PY (95% CI 3554–3622), with cardiovascular-related conditions alone exceeding the costs attributed to COPD ($1375/PY versus $904/PY). Conclusion Despite multifaceted prevention and management initiatives, COPD-related economic burden is increasing, with the majority of costs due to comorbid conditions. Rising per-patient costs, combined with the flat or increasing prevalence of COPD in many jurisdictions, indicates a significant increase in COPD burden.
Resource-rational contractualism: A triple theory of moral cognition
Authors: Sydney Levine, Nick Chater, Joshua B. Tenenbaum, Fiery Cushman
Journal: Behavioral and Brain Sciences (2024)

It is widely agreed upon that morality guides people with conflicting interests towards agreements of mutual benefit. We therefore might expect numerous proposals for organizing human moral cognition around the logic of bargaining, negotiation, and agreement. Yet, while "contractualist" ideas play an important role in moral philosophy, they are starkly underrepresented in the field of moral psychology. From a contractualist perspective, ideal moral judgments are those that would be agreed to by rational bargaining agents-an idea with wide-spread support in philosophy, psychology, economics, biology, and cultural evolution. As a practical matter, however, investing time and effort in negotiating every interpersonal interaction is unfeasible. Instead, we propose, people use abstractions and heuristics to efficiently identify mutually beneficial arrangements. We argue that many well-studied elements of our moral minds, such as reasoning about others' utilities ("consequentialist" reasoning) or evaluating intrinsic ethical properties of certain actions ("deontological" reasoning), can be naturally understood as resource-rational approximations of a contractualist ideal. Moreover, this view explains the flexibility of our moral minds-how our moral rules and standards get created, updated and overridden and how we deal with novel cases we have never seen before. Thus, the apparently fragmentary nature of our moral psychology-commonly described in terms of systems in conflict-can be largely unified around the principle of finding mutually beneficial agreements under resource constraint. Our resulting "triple theory" of moral cognition naturally integrates contractualist, consequentialist and deontological concerns.
Targeting neutrophil serine proteases in bronchiectasis
Authors: James D. Chalmers, Marcus A. Mall, Sanjay H. Chotirmall, Anne E. O'Donnell, Patrick A. Flume, Naoki Hasegawa, Felix C. Ringshausen, Henrik Watz, Jin-Fu Xu, Michal Shteinberg, Pamela J. McShane
Journal: European Respiratory Journal (2024)

Persistent neutrophilic inflammation is a central feature in both the pathogenesis and progression of bronchiectasis (BE). Neutrophils release neutrophil serine proteases (NSPs), such as neutrophil elastase, cathepsin G and proteinase 3. When chronically high levels of free NSP activity exceed those of protective antiproteases, structural lung destruction, mucosal-related defects, further susceptibility to infection and worsening of clinical outcomes can occur. Despite the defined role of prolonged, high levels of NSPs in BE, no drug that controls neutrophilic inflammation is licensed for the treatment of BE. Previous methods of suppressing neutrophilic inflammation (such as direct inhibition of neutrophil elastase) have not been successful; however, an emerging therapy designed to address neutrophil-mediated pathology, inhibition of the cysteine protease cathepsin C (CatC, also known as dipeptidyl peptidase 1), is a promising approach to ameliorate neutrophilic inflammation, since this may reduce the activity of all NSPs implicated in BE pathogenesis, and not just neutrophil elastase. Current data suggest that CatC inhibition may effectively restore the protease–antiprotease balance in BE and improve disease outcomes as a result. Clinical trials for CatC inhibitors in BE have reported positive Phase III results. In this narrative review, we discuss the role of high NSP activity in BE, and how this feature drives the associated morbidity and mortality seen in BE. This review discusses therapeutic approaches aimed at treating neutrophilic inflammation in the BE lung, summarising clinical trial outcomes, and highlighting the need for more treatment strategies that effectively address chronic neutrophilic inflammation in BE.
ECG-based risk factors for adverse cardiopulmonary events and treatment outcomes in COPD
Authors: R. Chad Wade, Fernando J. Martinez, Gerard J. Criner, Lee Tombs, David A. Lipson, David M.G. Halpin, MeiLan K. Han, Dave Singh, Robert A. Wise, Ravi Kalhan, Mark T. Dransfield
Journal: European Respiratory Journal (2024)

Background COPD has high mortality, compounded by comorbid cardiovascular disease. We investigated two electrocardiogram (ECG) markers, Cardiac Infarction Injury Score (CIIS) and P pulmonale, as prognostic tools for adverse cardiopulmonary events in COPD. Methods Post hoc analysis of the IMPACT trial. Outcomes included odds (odds ratio [95% confidence intervals]) of adverse cardiopulmonary events stratified by CIIS threshold (&lt;20/≥20) and P pulmonale (baseline). Events included all-cause death, hospitalisation/death, cardiovascular adverse event of special interest (CVAESI), severe COPD exacerbations, and moderate/severe COPD exacerbations. Effects of fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) versus FF/VI or UMEC/VI based on CIIS and P pulmonale were also assessed. Results We included 9448 patients. Patients with CIIS ≥20 had greater odds of all-cause death (1.73[1.27–2.37]; p &lt;0.001), hospitalisation/death (1.33[1.17–1.50]; p &lt;0.001), CVAESI (1.27[1.08–1.48]; p &lt;0.005), severe COPD exacerbations (1.41[1.21–1.64]; p &lt;0.001) and moderate/severe COPD exacerbations (1.25[1.13–1.40]; p &lt;0.001) versus CIIS &lt;20. Patients with P pulmonale ( versus without) had greater odds of all-cause death (2.25[1.54–3.29]; p &lt;0.001), hospitalisation/death (1.51[1.28–1.79]; p &lt;0.001), severe COPD exacerbations (2.00[1.65–2.41]; p &lt;0.001) and moderate/severe COPD exacerbations (1.25[1.08–1.46]; p &lt;0.001). A combined model demonstrated patients with CIIS ≥20 and P pulmonale had increased risk of all-cause death (3.38[1.23–9.30]; p=0.019), hospitalisation/death (1.61[1.14–2.22]; p=0.004), and rate of severe COPD exacerbations (1.89[1.22–2.91]; p=0.004) and moderate/severe COPD exacerbations (1.25[1.00–1.56]; p=0.046). The risk of all-cause death and CVAESI was reduced with FF/UMEC/VI versus UMEC/VI in patients with CIIS ≥20, but not CIIS &lt;20. Conclusions These findings suggest potential clinical relevance of CIIS and P pulmonale as risk indicators for adverse cardiopulmonary events in COPD.
Body mass index trajectories from birth to early adulthood and lung function development
Authors: Gang Wang, Jenny Hallberg, Simon Kebede Merid, Ashish Kumar, Susanna Klevebro, Baninia Habchi, Romanas Chaleckis, Craig E. Wheelock, Natalia Hernandez-Pacheco, Sandra Ekström, Christer Janson, Inger Kull, Anna Bergström, Erik Melén
Journal: European Respiratory Journal (2024)

Background Limited studies have investigated the influence of body mass index (BMI) trajectories on lung function covering the entire growth period. Methods We conducted a prospective study utilizing data from the Swedish BAMSE birth cohort. Latent class mixture modelling was employed to examine the diversity in BMI z-scores from birth to 24 years of age. Participants with four or more BMI z-scores were included (n=3204, 78·4%). Pre-bronchodilator (BD) spirometry was tested at 8, 16, and 24 years, while post-BD spirometry, multiple-breath nitrogen washout (for lung clearance index, LCI), and urinary metabolomics data were assessed at 24 years. Results Six distinct BMI development groups were identified. Compared to the stable normal BMI group, the accelerated increasing BMI group exhibited reduced pre- and post-BD FEV 1 /FVC ratio z scores (β=-0·26, 95% CI=[-0·44, −0·08], and −0·22, [ −0·39, −0·05], respectively), along with elevated LCI (0·30, [0·22, 0·42]) at 24 years. The persistent high BMI group demonstrated lower FEV 1 , and FVC z scores growth between 16 and 24 years (−0.24, [-0.42, −0.05], and −0.27, [-0.45, −0.01], respectively), and elevated LCI (0·20, [0·03, 0·39]) at 24 years. However, those impairments were not observed in the accelerated resolving BMI group. Conversely, the persistent low BMI group displayed persistently decreased FEV 1 , and FVC from 8 to 24 years, as well as decreased lung function growth. Additionally, histidine-related metabolites were associated with pre- and post-BD FEV 1 (hypergeometric FDR=0.008 and &lt;0.001, respectively). Conclusions Early interventions aiming for normal BMI during childhood may contribute to improved lung health later in life.
Impact of Population Health Management to Modify Disparate Use of SGLT2 Inhibitors/Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs)
Authors: Linda-Marie Ustaris Lavenburg, Zhuoheng Han, Mitra Mosslemi, Alaa A. Alghwiri, Thomas D. Nolin, Melanie R. Weltman, Jonathan Guerrero Yabes, Manisha Jhamb
Journal: Journal of the American Society of Nephrology (2024)
MIP Assay-Based Targeted Gene Resequencing Identifies 22 Novel and Extremely Rare Variants in Known and Putative New Candidate Genes in Lower Urinary Tract Obstruction
Authors: Markus Hartmut Zeilmann, Arif Ekici, Clara Vidic, Wolfgang Krebs, Marcin Zaniew, Agnieszka Szmigielska, Monika Miklaszewska, Maria Szczepanska, Katarzyna Taranta-Janusz, Przemyslaw Sikora, Katarzyna Zachwieja, Friedhelm Hildebrandt, Alina Hilger
Journal: Journal of the American Society of Nephrology (2024)
Heterogeneity in the Renal Thick Ascending Limb Cell Composition: Insights from Ultrastructure, Immunohistochemistry, and Single-Cell Transcriptomics
Authors: Hasan Demirci, Jessica Paola Bahena-López, Jonathan W. Nelson, Xiao-Tong Su, David H. Ellison, Sebastian Bachmann
Journal: Journal of the American Society of Nephrology (2024)
A Case of Secondary Membranous Nephropathy Caused by Rheumatoid Arthritis Accompanied by Double Positive for Anti-GBM Antibodies and Proteinase 3 (PR3)-ANCA
Authors: Saki Kawamori, Hitoshi Suzuki, Mingfeng Lee, Yukako Umezawa, Yuya Sasatsuki, Masahiro Muto, Hisatsugu Takahara, Shigeki Tomita, Yusuke Suzuki
Journal: Journal of the American Society of Nephrology (2024)
Dialysis after Graft Loss: Preliminary Findings of a Large Multinational Database
Authors: Oshini Shivakumar, Xiaoling Ye, John W. Larkin, Peter Kotanko, Benjamin E. Hippen, Adrian M. Guinsburg, Jochen G. Raimann, Damien Ashby, Frederick W.K. Tam, Hutan Ashrafian
Journal: Journal of the American Society of Nephrology (2024)
Identification of Kidney Transcripts Associated with Prognosis in ANCA-Associated Glomerulonephritis
Authors: Benoit Brilland, Jérémie Riou, Andrea Boizard-Moracchini, Nathalie Merillon, Maïa Despre, Giorgina B. Piccoli, Assia Ilham Djema, Nicolas Henry, Marie-Christine Copin, David Langlais, Patrick Blanco, Jean francois Augusto
Journal: Journal of the American Society of Nephrology (2024)
AKI in Care Transitions (ACT): A Randomized Controlled Feasibility Trial
Authors: Caroline B. Ledet, Heather P. May, Kristin C. Cole, Joan M. Griffin, Joseph Herges, Kianoush Kashani, Andrea G. Kattah, Rozalina G. Mccoy, Angeliki G. Tinaglia, Andrew D. Rule, Erin F. Barreto
Journal: Journal of the American Society of Nephrology (2024)
IgM Dominant Proliferative Glomerulonephritis (GN), Undetectable Serum C4, and Chronic Lymphocytic Leukemia (CLL) with Persistently Negative Serological Testing for Type 1 Cryoglobulins
Authors: Raghunandan Konda, Dana V. Rizk, Arun Rajasekaran
Journal: Journal of the American Society of Nephrology (2024)
Urine Epidermal Growth Factor as a Potential Biomarker of Functional Kidney Mass for the Evaluation of Kidney Transplant Donors and Recipients
Authors: Adriana Hernández Andrade, Bernardo Juarez Cuevas, Valeria Navarro Sanchez, Jesus Alejandro Sanchez Ramirez, Alberto Nordmann-Gomes, María Fernanda Zavala Miranda, Cristino Cruz Rivera, Luis E. Morales-Buenrostro, Juan M. Mejia-Vilet
Journal: Journal of the American Society of Nephrology (2024)
Inhibitory Dynamics of SBI-425 on Medial Arterial Calcification in Mice with CKD: A Therapeutic Perspective
Authors: Takashi Tani, Hitomi Tani, Akiko Mii, Rei Nakazato, Natsumi Kamijo, Akira Shimizu, Yukinao Sakai
Journal: Journal of the American Society of Nephrology (2024)
Kidney-Targeted Delivery of Nonviral Nucleic Acids Using Noninvasive Transcutaneous Ultrasound Enables Safe, Re-dosable, Titratable, and Durable Gene Expression in Mice and Nonhuman Primates
Authors: Bert J. Frederich, Jonathan Chan, Surabhi Rao, Victor Foster, Adel Alonso, Celia Ortiz, Elizabeth Del Greco, Oliver Chen, David Satyadi, David Kim, Dhruv Bole, Nana Ingram, Katie Benthall, Margarita Krivega, Julia Poniatowski, Tanaya Ghosh, Belinda Cabriga, Charles S. Levine, Ivan Krivega, Kenneth Greenberg, Steven Feinstein
Journal: Journal of the American Society of Nephrology (2024)
Association of Macronutrients with CKD Progression in West Africans
Authors: Edward Papa Kwabena Kwakyi, Runqi Zhao, Yemi R. Raji, Manmak Mamven, Tolulope V. Adebile, Adaobi Solarin, Nanna R. Ripiye, Theophilus I. Umeizudike, Ifeoma I. Ulasi, Dwomoa Adu, Rasheed A. Gbadegesin, Rulan S. Parekh, Akinlolu Ojo, Diane C. Mitchell, Sushrut S. Waikar, Titilayo O. Ilori
Journal: Journal of the American Society of Nephrology (2024)
SGLT2 Inhibitors Attenuate Protein Abundance of Collectin Kidney 1 and Mannose-Binding Lectin in the Kidney and Liver in Mice with Experimental Diabetes
Authors: Mia Jensen, Camilla Enggaard, Steffen Thiel, Yaseelan Palarasah, Per Svenningsen, Boye Jensen
Journal: Journal of the American Society of Nephrology (2024)
Uremia, Angioplasty Injury, and Vessel Type (Artery vs. Vein) Activate Differential Gene Expression and Pathway Profiles
Authors: Unimunkh Uriyanghai, Christine Wai, Huanjuan Su, Eyla C. Arteaga, Vinay A. Sudarsanam, Samuel Haddad, Edward Moreira Bahnson, Prabir Roy-Chaudhury, Gang Xi
Journal: Journal of the American Society of Nephrology (2024)
Accuracy of Inferior Vena Cava (IVC) and Lung Point-of-Care Ultrasonography (POCUS) as an Adjunct in the Evaluation of Hypervolemia among Patients on Maintenance Hemodialysis
Authors: Denise C. De Los Reyes, Annabelle Sy Lim, Vonn Velasco
Journal: Journal of the American Society of Nephrology (2024)
Construction of a Predictive Equation for CKD Exacerbation by Multifactorial Analysis Using Machine Learning and Analysis on Differences in CKD Exacerbation Factors in Each CKD Stage
Authors: Koki Ogawa, Hiroaki Hara, Yasushi Takahashi, Seiko Oana, Yumiko Nakamura, Akito Maeshima, Hajime Hasegawa
Journal: Journal of the American Society of Nephrology (2024)
Regional Differences in Kidney Replacement Therapy in Diabetic Kidney Disease: Apollo Dial DB
Authors: Yue Jiao, Melanie Wolf, Kaitlyn Renee Croft, Paola Carioni, Mitesh Soni, Anke Winter, Luca Neri, Sheetal Chaudhuri, Kanti Singh, Milind Nikam, Stefano Stuard, Adrian M. Guinsburg, Dinesh K. Chatoth, Jeffrey L. Hymes, Kirill Koulechov, Len A. Usvyat, John W. Larkin, Franklin W. Maddux
Journal: Journal of the American Society of Nephrology (2024)
Dietary Fiber-Derived Microbial Metabolites Prevent Acute and Chronic Kidney Ischemia-Reperfusion Injury (IRI) through G Protein-Coupled Receptor GPR43
Authors: Alexander Gilbert, Anita Chitsaz, Guozhen Zhu, Julian J. Singer, Steven J. Chadban, Huiling Wu
Journal: Journal of the American Society of Nephrology (2024)
Genome-Wide Glomerular Allele-Specific Expression in Human Proteinuric Kidney Tissue
Authors: Ana C. Onuchic-Whitford, Junmo Sung, Erotokritos Sakkas, Michelle Mcnulty, Anya Greenberg, Jihoon Yoon, Sowmya Badina, Matt G. Sampson, Dongwon Lee
Journal: Journal of the American Society of Nephrology (2024)
Impact of Proteinuric Glomerular Disease on Educational Outcomes in the Cure Glomerulonephropathy (CureGN) Study
Authors: Mahie M. Abdullah, Matthew Schuchman, Laura J. Castellanos, Pamela Singer, Abby Miriam Basalely, Carol Liu Shen, Rachel Frank, Suzanne Vento, Christine B. Sethna
Journal: Journal of the American Society of Nephrology (2024)
Trends in Dialysis Facility Access in the United States from 2018-2023 and Association with Area Socioeconomic Disadvantage
Authors: Meri Varkila, Maria E. Montez-Rath, Xue Yu, Nivetha Subramanian, Glenn M. Chertow, Julie Parsonnet, Shuchi Anand
Journal: Journal of the American Society of Nephrology (2024)
PDZD8, a Tethering Protein of Endoplasmic Reticulum (ER)-Lysosome Interaction, Alters Tubular Inflammation in Mice with Cisplatin-Induced AKI
Authors: Yuto Takenaka, Sho Hasegawa, Yu Ah Hong, Qi Li, Hiroshi Maekawa, Masaomi Nangaku, Reiko Inagi
Journal: Journal of the American Society of Nephrology (2024)
Effects of Semaglutide on Kidney Parameters in Patients with Obesity and Nondiabetic CKD
Authors: Hiddo Jan L. Heerspink, Ellen M. Apperloo, Niels Jongs, Secundino Cigarran, Maria Jose Soler, Josep M. Cruzado, Annemarie B. van der Aart, Gozewijn Dirk Laverman, Jacobien Verhave, Sofia B. Ahmed, Roland E. Schmieder, Christoph Wanner, David Cherney, Jose L. Gorriz
Journal: Journal of the American Society of Nephrology (2024)
Cardiorenal Outcomes in Patients with IgAN: The FinnGen Study
Authors: Tomas Juhani Visser, Laura Pyle, Phoom Narongkiatikhun, Ye Ji Choi, David Cherney, Rodosthenis S. Rodosthenous, Krzysztof Kiryluk, Petter Bjornstad, Teemu Niiranen, Patrik Finne, Daniel Gordin
Journal: Journal of the American Society of Nephrology (2024)
Paradox of Precision: More Parameters, Fewer Complications in Kidney Biopsy Outcomes
Authors: Joao Mateus E Lima Souza, Marclebio M.C. Dourado, Maria Zayne Nogueira de Azevedo, Ana Paula Gueiros, Thiago Vinícius Paulo Paiva, Breno Matheus dos Santos Sá, Tiago Moura Freitas
Journal: Journal of the American Society of Nephrology (2024)
A Postmarketing Study Assessing Safety and Efficacy of Velphoro in Korean Adult Dialysis Patients
Authors: Weiwei Qi, Won Min Hwang, Shin-Young Ahn, Young-Ki Lee, Byung Chul Shin, Jong hoon Lee, Seon Gun Kim, Hye-Jung Kim, Manuela Stauss-Grabo, Carmen So, Astrid Feuersenger
Journal: Journal of the American Society of Nephrology (2024)
Venous Excess Ultrasound (VExUS) and Lung Ultrasound (LUS) in Post-transplant (PosKTx) Volume Assessment (VA): Is There a Place for Them?
Authors: Haridian Sosa Barrios, Irene Minguez, Victor Burguera, Cristina Galeano, Sandra Elias, Miriam Roncal Redin, Jorge Sánchez, Raquel Moreno Garcia, Milagros Fernandez-Lucas, Maite Rivera Gorrin
Journal: Journal of the American Society of Nephrology (2024)
Safety and Efficiency Evaluation of Carbon Dioxide Removal in Combination with Continuous Veno-Venous Hemodialysis/Hemodiafiltration Therapy: Baseline Characteristics of the multiECCO2R Study
Authors: Anna Patrizia Wammi, Stefan Kluge, Dominik Jarczak, Carsten Willam, Stefan Helmut Blaas, Bertram Ottillinger, Natalia Korolev, Jennifer Braun, Manuela Stauss-Grabo
Journal: Journal of the American Society of Nephrology (2024)